Stay updated on Daratumumab in PGNMID and C3 GN Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.

Latest updates to the Daratumumab in PGNMID and C3 GN Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange Detected- Updated page revision tag from v3.4.1 to v3.4.2; no impact on study content or user workflow.SummaryDifference0.1%

- Check20 days agoChange DetectedAn administrative version update is shown: 'Revision: v3.4.1' was added and 'Revision: v3.4.0' was removed. This appears to be metadata about the site and does not alter study data or page content.SummaryDifference0.1%

- Check34 days agoChange DetectedAdded UI elements and labels: Show glossary and Hide glossary, and updated metadata fields with 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', plus Revision: v3.4.0. Removed or replaced older labels: 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4.SummaryDifference0.4%

- Check41 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing Revision: v3.3.3. No substantive content or layout changes are evident.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded Minnesota as a location under the Locations section and removed the HHS Vulnerability Disclosure text/link from the footer.SummaryDifference0.2%

- Check93 days agoChange DetectedAdded: a note that publications are automatically filled from PubMed and may not be about the study, and a new revision tag (v3.3.2); removed the older PubMed-origin text and the earlier revision tag (v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Daratumumab in PGNMID and C3 GN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.